The major flexibilities in the Indian Patent Act - Section 3(d) and the compulsory licensing system - to make medicines affordable, have been under-implemented.
YOU DESERVE INDEPENDENT, CRITICAL MEDIA.
We want readers like you.
Support independent, critical media.
Charts & Maps
